HSBC cuts Smith & Nephew stock rating, lowers price target

Published 25/04/2025, 09:26
HSBC cuts Smith & Nephew stock rating, lowers price target

On Friday, HSBC analysts downgraded Smith & Nephew PLC (LON:SN:LN) (NYSE:SNN) stock from Buy to Hold, adjusting the price target to GBP10.70 from the previous GBP11.60. The revision comes despite acknowledging the potential of the company’s new 12-point program introduced by the CEO, which HSBC believes is more likely to yield positive results compared to past strategies. The program is noted for its specific Key Performance Indicators (KPIs) aimed at addressing the company’s critical issues.

HSBC’s assessment recognizes that Smith & Nephew has historically traded at a discount compared to its peers, and there is an opportunity to capitalize on the growing importance of Ambulatory Surgery Centers (ASC) with its smaller robotic product. However, the firm also points out the challenges Smith & Nephew faces, particularly in the US knees and hips market, where the company has experienced several years of consecutive underperformance.

The analyst from HSBC commented on the new initiative led by Smith & Nephew’s CEO, stating, "Smith and Nephew’s 12-point program announced by the current CEO comes across more convincingly than previous plans, in our view, with specific KPIs that directly address the pain points." This suggests that the new strategy has clear goals and a focus on addressing the company’s weaknesses.

Despite the optimism surrounding the new program, HSBC remains cautious due to the company’s historical underperformance in the US. The analyst added, "Although we still believe there is plenty of upside that can be achieved via a successful turnaround of the business, the underperformance, especially in the US knees and hips business, might be difficult to turn around after several years of sequential underperformance."

In summary, while HSBC sees potential for Smith & Nephew’s turnaround strategy to be effective, the firm has tempered its expectations due to the ongoing challenges in the US market, leading to the downgrade in stock rating and the lowered price target.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.